Furthermore, it has also been proposed that LSD1 inhibition induces TGFβ expression in tumor cells, leading to suppressed cytotoxicity of CD8+ T cells, thus limiting the immunotherapeutic efficacy of LSD1 inhibitors. Here, KDM1A is linked to neoplasm.